Repository logo
 

Munc18-2 is required for Syntaxin 11 Localization on the Plasma Membrane in Cytotoxic T-Lymphocytes.


Type

Article

Change log

Authors

Dieckmann, Nele MG 
Hackmann, Yvonne 
Aricò, Maurizio 
Griffiths, Gillian M 

Abstract

Cytotoxic T-lymphocytes (CTL) kill their targets by cytolytic granule secretion at the immunological synapse. The Sec/Munc protein, Munc18-2, and its binding partner Syntaxin 11 (STX11) are both required for granule secretion, with mutations in either leading to the primary immunodeficiency, Familial Haemophagocytic Lymphohistiocytosis (FHL4 and 5). Understanding how Munc18-2 and STX11 function in CTL has been hampered by not knowing the endogenous localization of these proteins. Using a novel FHL5 Munc18-2 mutation that results in loss of protein, cytotoxicity and degranulation together with CTL from an FHL4 patient lacking STX11, enabled us to localize endogenous STX11 and Munc18-2 in CTL. Munc18-2 localized predominantly to cytolytic granules with low levels associated with the plasma membrane where STX11 localized. Importantly, while Munc18-2 localization is unaffected by the absence of STX11 in FHL4 CTL, STX11 is lost from the plasma membrane in FHL5 CTL lacking Munc18-2. These findings support a role for Munc18-2 in chaperoning STX11 to the plasma membrane where the final fusion events involved in secretion occur.

Description

Keywords

CTL, FHL4, FHL5, Munc18-2, Syntaxin 11, Cell Membrane, Cells, Cultured, Humans, Infant, Lymphohistiocytosis, Hemophagocytic, Microscopy, Fluorescence, Munc18 Proteins, Mutation, Protein Transport, Qa-SNARE Proteins, T-Lymphocytes, Cytotoxic

Journal Title

Traffic

Conference Name

Journal ISSN

1398-9219
1600-0854

Volume Title

16

Publisher

Wiley
Sponsorship
Wellcome Trust (103930/Z/14/Z)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (75880)
his work was funded by grants from the Wellcome Trust [075880], [100140] and [097024/B/11/Z] (G.M.G); a Daimler Benz scholarship (Y.H.); the Kendal-Dixon Fund (Y.H.); the Cambridge European Trust (Y.H.); King’s College (Cambridge) (Y.H.); the National Institute for Health Research Biomedical Research Center (G.M.G); Antonio Pinzino – Associazione per la Ricerca sulle Sindromi Emofagocitiche (M.A.); Associazione Italiana Ricerca istiocitosi (M.A.); and Italian Ministry of Health, Progetti dioe ricerca finalizzata 2008, Bando Malattie Rare RF-TOS-2008-1219488 (M.A.).